Scottish Cardiac Society 35th Annual General Meeting 2026

Introduction

Dr Stuart Watkins, President, Scottish Cardiac Society

Updates in Endocarditis

Dr Fiona Thorburn, Consultant Infectious Diseases & Microbiology, Golden Jubilee National Hospital, Clydebank

Hypertension

Professor Thomas MacDonald, Emeritus Professor, University of Dundee

Spontaneous Coronary Artery Dissection (SCAD)

Dr Anne Scott, Consultant Cardiologist, Forth Valley Royal Hospital, Larbert

Postural Orthostatic Tachycardia Syndrome (POTS)

Dr Simon Beggs, Consultant Cardiologist, NHS Greater Glasgow & Clyde

Long QT Syndrome

Speaker tbc

Transcatheter Aortic Valve Implantation (TAVI)

Dr Rong Bing, Cardiologist, NHS Lothian

Percutaneous Coronary Intervention for chronically occluded arteries

Dr Andy Stewart, Consultant Interventional Cardiologist, Aberdeen Royal Infirmary

Acute Aortic Syndromes

 Mr George Gradinaru, Consultant Cardiac Surgeon, Golden Jubilee National Hospital, Clydebank

Clinical impact of MYH7 variants in Hypertrophic cardiomyopathy

Aditya Pandey, Medical Students, Wolfson Medical School Building, University of Glasgow, Adithi Bhat, Medical Student, Wolfson Medical School Building, University of Glasgow

Efficacy and Safety of Single-Sample Rule-Out Pathways with High-sensitivity Cardiac Troponin for Myocardial Infarction: Meta-Analysis of Randomised Controlled Trials

Amber Pollock, Foundation Year 1 doctor, British Heart Foundation Centre for Research Excellence, University of Edinburgh

Valve in Valve Transcatheter Aortic Valve Implantation in a Radiolucent Bioprosthetic Surgical Valve Prothesis

Jack Elliot, Medical Student, University of Glasgow

Cholesterol Reduction Following Acute Coronary Syndrome in the West of Scotland: Are We Meeting Guideline-Directed Targets?

Yen Wing Ng, Cardiology Clinical Fellow, Golden Jubilee National Hospital

Clinical outcomes in consecutive patients with type 2 myocardial infarction

Benjamin JL Lim, Medical Student, University of Edinburgh

In vivo evidence of persistent cardiac fibroblast activation following anthracycline therapy: A prospective hybrid PET-MR study

Dr Tariq Ramtoola, Clinical Research Fellow, University of Edinburgh

The Cardio-Renal-Metabolic Clinic: SGLT2 Inhibitors & GLP-1 Receptor Agonists in 2026

Dr Matthew Lee, Cardiology Clinical Senior Lecturer & Honorary Consultant Cardiologist, University of Glasgow & Glasgow Royal Infirmary

PHARMACOLOGY — Quadruple therapy in HFrEF: Have we reached the pharmacological ceiling?

Speaker tbc

Conduction system pacing: Has left bundle branch area pacing become the new standard of care?

Dr Jagdeep Singh, Consultant Cardiologist, Victoria Hospital, Kirkcaldy

DEVICES - Pulsed field ablation for AF: a game changer

Professor Derek Connelly, Professor and Lead Clinician, Electrocardiology Research Group, and Honorary consultant cardiologist, University of Glasgow

PATHWAYS - MINOCA & INOCA — From exclusion diagnosis to structured diagnostic pathway

Professor Vijay Kunadian, Professor of Interventional Cardiology and Cardiovascular Medicine, Newcastle University

INVITED GUEST LECTURE

Introduced by Dr Stuart Watkins, President, Scottish Cardiac Society

Cardiology in the Age of AI: Smarter decisions and clinical judgement in the algorithmic era

Dr Asif Qasim, Consultant Cardiologist, Kings College Hospital, Croydon & Cleveland Clinic

End of session reflections

Dr Stuart Watkins, President, Scottish Cardiac Society

SCS Drinks reception & Society Dinner & Quiz

Hosted by Dr Benedict Wiles

What’s changed in cardiology this year — Key late-breaking trials 2025–26

Speaker tbc

Guideline update — New / Updated guidelines in 2025–26 and what it means for practice

Dr Jonathan Watt, Consultant Cardiologist, NHS Highland

Clinician-Statistician mindset: 'I've read the trial — But should I believe it?' practical tools for critical appraisal

Speaker tbc

Cardiac Fibroblast Activation as a Novel Molecular Imaging Biomarker in Hypertrophic Cardiomyopathy: A Prospective Positron Emission Tomography Study

Dr Tariq Ramtoola, Clinical Research Fellow, University of Edinburgh

Combined Atrial Fibrillation Clinic: 1-stop Cardioversion, AF risk factors identification/modifications, cardiologist review & antiarrhythmic drugs initiation service

Dr Batrisyia Haji Rakawih, FY1 Royal Alexandra Hospital, Paisley

Digital transformation of cardiac implantable electronic device services in a large National Health Service health board: seven-month outcomes following implementation of a purpose-built electronic device management platform

Ben Macfarlane, Medical Student, University of Glasgow

Permanent pacemaker implantation following transcatheter aortic valve implantation: implantation rates, indications, and pacing burden

Dr Greg Bear, IMT3, Golden Jubilee National Hospital, Clydebank

Real-world experience of Mavacamten outcomes for hypertrophic cardiomyopathy: retrospective observation of 12-week initiation phase outcomes

Nicholas Lim, IMT3 Doctor, Manchester Foundation Trust

Severe Mitral Regurgitation — Imaging-guided decision-making: When to intervene

Dr Anne Scott, Consultant Cardiologist, Forth Valley Royal Hospital, Larbert

Cardiomyopathy Imaging — From phenotype to precision diagnosis

Dr Kenneth Mangion, Consultant in Cardiology & Imaging, NHS Golden Jubilee National Hospital, Clydebank

CONTROVERSY 1 — Mitral TEER - who should we do and should we be doing more in Scotland?

Speaker tbc

CONTROVERSY 2 - Coronary Revascularisation in Severe Aortic Stenosis: who, when and how?

Dr Nick Cruden, Consultant Cardiologist and Clinical Director for Cardiac Service, NHS Lothian

CONTROVERSY 3 — Are we over investigating patients with small elevations in HS Troponin?

Dr Ken Lee, BHF Intermediate Clinical Research Fellow and Honorary Consultant Cardiologist, University of Edinburgh

CONTROVERSY 4 — Should palliation in chronic heart failure be considered earlier in the patient pathway?

Mrs Yvonne Millerick, Heart Failure Palliative Care Nurse Consultant Lecturer, Glasgow Caledonian University

CONTROVERSY 5 — Should we be doing more CTCA to guide coronary Intervention?

Dr Richard Good, Consultant Cardiologist, University of Glasgow

SCS awards presentation and close of meeting

Dr Stuart Watkins, President, Scottish Cardiac Society